Sichuan Expressway Co Ltd (0107)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 4.810 |
|---|---|
| 52-week range | 4.230 – 6.100 |
| Return, 1 month / 3 months | +0.0% / +1.3% |
| Return, 1 year / 3 years | +1.0% / +161.4% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 25.1% |
| Worst drawdown (1 year) | -25.0% |
| Average daily value traded | 4.99M HKD |
| Dividend yield | 7.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sichuan Expressway Company builds, operates and manages toll expressways and related road infrastructure in Sichuan Province, China. Its customers are the drivers and transport operators who use its toll roads, and it also takes part in constructing and upgrading expressway projects. The company is based in Chengdu and raises part of its funding through listings on stock exchanges in Hong Kong and Shanghai. Alongside its core toll-road business, it has interests in related transport and infrastructure services.
On this site Sichuan Expressway Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0107, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sichuan Expressway Co Ltd (0107) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 4.810 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 284 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.0% and over the last three months it rose 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.1% | ||
| From 52-week high | -20.9% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.3% | ||
| 6-month return | -13.7% | ||
| 12-month return, skipping the last month | 1.0% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.0% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 4.99M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | +0.0% |
| 3 months | +1.3% |
| 6 months | −13.7% |
| 1 year | +1.0% |
| 3 years | +161.4% |
| 5 years | +252.5% |
Signals
| 50-day / 200-day average | 4.798 / 5.017 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.093 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | HKD 0.3402 |
| 4 Jun 2025 | HKD 0.3153 |
| 4 Jun 2024 | HKD 0.2635 |
| 6 Jun 2023 | HKD 0.1112 |
| 6 Jun 2022 | HKD 0.1289 |
| 1 Jun 2021 | HKD 0.0965 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.